PCWorld.com - Taiwan Tests Island-Wide WiMax: "Taiwan Tests Island-Wide WiMax
Government teams with Intel to build largest testing ground for new wireless technology.
Dan Nystedt, IDG News Service
Tuesday, October 18, 2005
TAIPEI -- Taiwanese government officials said on Monday they plan to make Taiwan the world's largest testing ground for WiMax, and inked a pact with Intel to work together on the wireless broadband technology.
The government will provide around $209 million in funding for the initiative, in addition to spectrum allocation and other assistance, while Intel is expected to pitch in its technical resources. Next year, the government will provide an additional $32.8 million in research funds specifically for WiMax, a separate budget from the above figure, said Minister of State Lin Ferng-ching.
Notebooks Ready
WiMax, also known as 802.16, is intended to provide users with wireless, high-speed Internet access at far greater distances than the current mainstream wireless technology, Wi-Fi.
Taiwan hopes to become a leader in developing products for WiMax, such as PC cards and notebook computers, as well as broadband services, by making itself a leader in the technology, according to Ho Mei-yueh, Taiwan's economics minister.
Taiwan chose to team up with Intel because the chip maker is among the staunchest proponents of WiMax and alre"
31 October 2005
DNC: Health News - Geneticists Unveil Powerful Tool for Understanding Disease: "Geneticists Unveil Powerful Tool for Understanding Disease
PDF Print E-mail
Written by Rita Jenkins| 27 October, 2005 19:18 GMT
a d v e r t i s e m e n t
HapMap haplotypes genetic research human evolution
'Data from the HapMap project allows scientists to select the particular DNA variants that provide the greatest information in the most efficient manner, lowering the costs and increasing the power of genetic research to identify the origin of disease.' Genetic researchers have made substantial advances in understanding the root causes of common diseases and the history of human evolution, according to a series of reports published in scientific journals this week.
Chief among these accomplishments is the work of an international consortium of more than 200 scientists from Canada, China, Japan, Nigeria, the United Kingdom and the United States published in the October 27 issue of the journal Nature.
The team studied DNA samples from four different parts of the world and concluded that genetic variants located physically close to each other are inherited collectively as groups, called haplotypes. The comprehensive catalog of all of these blocks is known as the 'HapMap.'
'Built upon the foundation laid by the human genome sequence, the HapMap is a powerful new tool for exploring the root causes of"
PDF Print E-mail
Written by Rita Jenkins| 27 October, 2005 19:18 GMT
a d v e r t i s e m e n t
HapMap haplotypes genetic research human evolution
'Data from the HapMap project allows scientists to select the particular DNA variants that provide the greatest information in the most efficient manner, lowering the costs and increasing the power of genetic research to identify the origin of disease.' Genetic researchers have made substantial advances in understanding the root causes of common diseases and the history of human evolution, according to a series of reports published in scientific journals this week.
Chief among these accomplishments is the work of an international consortium of more than 200 scientists from Canada, China, Japan, Nigeria, the United Kingdom and the United States published in the October 27 issue of the journal Nature.
The team studied DNA samples from four different parts of the world and concluded that genetic variants located physically close to each other are inherited collectively as groups, called haplotypes. The comprehensive catalog of all of these blocks is known as the 'HapMap.'
'Built upon the foundation laid by the human genome sequence, the HapMap is a powerful new tool for exploring the root causes of"
30 October 2005
Scientists discover stem cell trigger
Gareth Walsh
SCIENTISTS have made a breakthrough in cell research that they believe brings the prospect of drastic improvements in the treatment of diseases such as Parkinson’s and multiple sclerosis.
According to reports yesterday they have discovered the chemical trigger that causes stem cells from embryos to start developing into organs, raising the possibility of parts of the body being able to repair their own damage.
Scientists have already established that the stem cells found in embryos have the capacity to develop into all other types of human cell. Until now they have been unable to find the correct chemical mix to spur them artificially into changing into endoderm, the layer of cells in embryos that in turn gives rise to organs.
Researchers at CyThera, an American company, announced last week in Nature Biotechnology, the scientific journal, that they had developed a technique to produce highly enriched endoderm cultures. Their research proves that embryonic stem cells have the capacity to change in the laboratory into endoderm.
Emmanuel Baetge, scientific director of CyThera, said: “If you were to use human embryonic stem cells to make products that treat disease such as diabetes or liver failure, you would have to go through the endoderm stage to get (them).”
The CyThera research team described its work as “a critical step in generating scientifically and therapeutically useful cells”. It has also been hailed by colleagues who say that endoderm is notoriously difficult to obtain.
Gareth Walsh
SCIENTISTS have made a breakthrough in cell research that they believe brings the prospect of drastic improvements in the treatment of diseases such as Parkinson’s and multiple sclerosis.
According to reports yesterday they have discovered the chemical trigger that causes stem cells from embryos to start developing into organs, raising the possibility of parts of the body being able to repair their own damage.
Scientists have already established that the stem cells found in embryos have the capacity to develop into all other types of human cell. Until now they have been unable to find the correct chemical mix to spur them artificially into changing into endoderm, the layer of cells in embryos that in turn gives rise to organs.
Researchers at CyThera, an American company, announced last week in Nature Biotechnology, the scientific journal, that they had developed a technique to produce highly enriched endoderm cultures. Their research proves that embryonic stem cells have the capacity to change in the laboratory into endoderm.
Emmanuel Baetge, scientific director of CyThera, said: “If you were to use human embryonic stem cells to make products that treat disease such as diabetes or liver failure, you would have to go through the endoderm stage to get (them).”
The CyThera research team described its work as “a critical step in generating scientifically and therapeutically useful cells”. It has also been hailed by colleagues who say that endoderm is notoriously difficult to obtain.
Subscribe to:
Posts (Atom)
Posts
